ergoline and Kidney-Neoplasms

ergoline has been researched along with Kidney-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for ergoline and Kidney-Neoplasms

Article	Year
Cabergoline therapy of paraneoplastic Cushing syndrome in children. Pediatric blood & cancer, 2010, Volume: 55, Issue:3 Topics: Adolescent; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Kidney Neoplasms; Paraneoplastic Syndromes; Wilms Tumor	2010
Hormonally induced renal neoplasia in the male Syrian hamster and the inhibitory effect of 2-bromo-alpha-ergocryptine methanesulfonate. Journal of the National Cancer Institute, 1975, Volume: 54, Issue:6 One group of male Syrian hamsters received diethylstilbestrol (DES) over a period of 9 months. All developed widespread and severe renal tumors. Another group of male Syrian hamsters was given DES plus 2-bromo-alpha-ergocryptine methanesulfonate (CB154) over the same period. These hamsters either did not develop renal tumors or had renal tumors that were minimal in severity. DES treatment induced hyperplastic and neoplastic changes in the intermediate lobe of the pituitary glands of treated animals, increased the number of prolactin-secreting cells, and decreased the number of somatotrophin-secreting cells. Adding CB154 significantly inhibited those changes in the pituitary gland. Histopathologic and ultrastructural examinations indicated that the renal tumors were carcinomas originating from proximal convoluted tubules. Topics: Animals; Body Weight; Bromocriptine; Cell Count; Cricetinae; Diethylstilbestrol; Ergolines; Growth Hormone; Hyperplasia; Kidney Neoplasms; Kidney Tubules, Proximal; Male; Mesylates; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Testis	1975

Article

Year

Cabergoline therapy of paraneoplastic Cushing syndrome in children.

Pediatric blood & cancer, 2010, Volume: 55, Issue:3

Topics: Adolescent; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Kidney Neoplasms; Paraneoplastic Syndromes; Wilms Tumor

2010

Hormonally induced renal neoplasia in the male Syrian hamster and the inhibitory effect of 2-bromo-alpha-ergocryptine methanesulfonate.

Journal of the National Cancer Institute, 1975, Volume: 54, Issue:6

One group of male Syrian hamsters received diethylstilbestrol (DES) over a period of 9 months. All developed widespread and severe renal tumors. Another group of male Syrian hamsters was given DES plus 2-bromo-alpha-ergocryptine methanesulfonate (CB154) over the same period. These hamsters either did not develop renal tumors or had renal tumors that were minimal in severity. DES treatment induced hyperplastic and neoplastic changes in the intermediate lobe of the pituitary glands of treated animals, increased the number of prolactin-secreting cells, and decreased the number of somatotrophin-secreting cells. Adding CB154 significantly inhibited those changes in the pituitary gland. Histopathologic and ultrastructural examinations indicated that the renal tumors were carcinomas originating from proximal convoluted tubules.

Topics: Animals; Body Weight; Bromocriptine; Cell Count; Cricetinae; Diethylstilbestrol; Ergolines; Growth Hormone; Hyperplasia; Kidney Neoplasms; Kidney Tubules, Proximal; Male; Mesylates; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Testis

1975